Diesel exhaust particulate increases the size and complexity of lesions in atherosclerotic mice

Part Fibre Toxicol. 2013 Dec 11:10:61. doi: 10.1186/1743-8977-10-61.

Abstract

Objective: Diesel exhaust particulate (DEP), a major component of urban air pollution, has been linked to atherogenesis and precipitation of myocardial infarction. We hypothesized that DEP exposure would increase and destabilise atherosclerotic lesions in apolipoprotein E deficient (ApoE-/-) mice.

Methods: ApoE-/- mice were fed a 'Western diet' (8 weeks) to induce 'complex' atherosclerotic plaques, with parallel experiments in normal chow fed wild-type mice. During the last 4 weeks of feeding, mice received twice weekly instillation (oropharyngeal aspiration) of 35 μL DEP (1 mg/mL, SRM-2975) or vehicle (saline). Atherosclerotic burden was assessed by en-face staining of the thoracic aorta and histological examination of the brachiocephalic artery.

Results: Brachiocephalic atherosclerotic plaques were larger in ApoE-/- mice treated with DEP (59 ± 10%) than in controls (32 ± 7%; P = 0.017). In addition, DEP-treated mice had more plaques per section of artery (2.4 ± 0.2 vs 1.8 ± 0.2; P = 0.048) and buried fibrous layers (1.2 ± 0.2 vs 0.4 ± 0.1; P = 0.028). These changes were associated with lung inflammation and increased antioxidant gene expression in the liver, but not with changes in endothelial function, plasma lipids or systemic inflammation.

Conclusions: Increased atherosclerosis is caused by the particulate component of diesel exhaust producing advanced plaques with a potentially more vulnerable phenotype. These results are consistent with the suggestion that removal of the particulate component would reduce the adverse cardiovascular effects of diesel exhaust.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Airway Remodeling / drug effects
  • Animals
  • Aorta, Thoracic / drug effects
  • Aorta, Thoracic / metabolism
  • Aorta, Thoracic / pathology
  • Apolipoproteins E / genetics
  • Blood Coagulation / drug effects
  • Brachiocephalic Trunk / drug effects
  • Brachiocephalic Trunk / metabolism
  • Brachiocephalic Trunk / pathology
  • C-Reactive Protein / analysis
  • Disease Models, Animal
  • Fibrinogen / analysis
  • Lipids / blood
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Oropharynx / metabolism
  • Oxidative Stress / drug effects*
  • Particulate Matter / pharmacokinetics
  • Particulate Matter / toxicity*
  • Plaque, Atherosclerotic / blood
  • Plaque, Atherosclerotic / chemically induced*
  • Plaque, Atherosclerotic / metabolism
  • Plaque, Atherosclerotic / pathology*
  • Pneumonia / chemically induced
  • Pneumonia / metabolism
  • Pneumonia / pathology
  • Vehicle Emissions / toxicity*

Substances

  • Apolipoproteins E
  • Lipids
  • Particulate Matter
  • Vehicle Emissions
  • Fibrinogen
  • C-Reactive Protein